Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch; Ewan A. Langan; Nina van Beek; Khalaf Kridin; Enno Schmidt; Detlef Zillikens; Ralf J. Ludwig; Christoph M. Hammers; Katja Bieber

doi:10.2340/actadv.v102.4490

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch, Ewan A. Langan, Nina van Beek, Khalaf Kridin, Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Christoph M. Hammers^*, Katja Bieber

^*Korrespondierende/r Autor/-in für diese Arbeit

Bar-Ilan University

Originalsprache	Englisch
Aufsatznummer	adv00835
Zeitschrift	Acta Dermato-Venereologica
Jahrgang	102
ISSN	0001-5555
DOIs	https://doi.org/10.2340/actadv.v102.4490
Publikationsstatus	Veröffentlicht - 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.2340/actadv.v102.4490

Andere Dateien und Links

Link to publication in Scopus

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen
Sadik, C., Zillikens, D., Scheffold, A., Schmidt, E., Heine, G., Manz, R., Köhl, J., Ludwig, R., Peipp, M., Hammers, M. C., Verschoor, A., Karsten, C., Nimmerjahn, F., Hutloff, A., Ibrahim, S., Wettschureck, N., Bieber, K., Schilf, P., Vaeth, M., Hirose, M., Vaeth, M., Baines, J. F., Bacher, P., Hoffmann, M., Busch, H. S., Höppner, M., Becker, M., Holtsche, M. M., Fähnrich, A., Szymczak, S., Murthy, S. & Lux, A.
01.01.22 → …
Projekt: DFG-Projekte › DFG-Verbundforschung: Sonderforschungsbereiche/ Transregios

Zitieren

@article{5f5f4d5dcc164eb792ef9bc32864922b,

title = "Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris",

author = "Katharina Boch and Langan, {Ewan A.} and {van Beek}, Nina and Khalaf Kridin and Enno Schmidt and Detlef Zillikens and Ludwig, {Ralf J.} and Hammers, {Christoph M.} and Katja Bieber",

note = "Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. The study was approved by the institutional review board (Uni-versity of L{\"u}beck, #12-178) and performed in accordance with the Declaration of Helsinki.",

year = "2022",

doi = "10.2340/actadv.v102.4490",

language = "English",

volume = "102",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

}

TY - JOUR

T1 - Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

AU - Boch, Katharina

AU - Langan, Ewan A.

AU - van Beek, Nina

AU - Kridin, Khalaf

AU - Schmidt, Enno

AU - Zillikens, Detlef

AU - Ludwig, Ralf J.

AU - Hammers, Christoph M.

AU - Bieber, Katja

N1 - Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. The study was approved by the institutional review board (Uni-versity of Lübeck, #12-178) and performed in accordance with the Declaration of Helsinki.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85143993164&partnerID=8YFLogxK

U2 - 10.2340/actadv.v102.4490

DO - 10.2340/actadv.v102.4490

M3 - Comments/Debates

C2 - 36511332

AN - SCOPUS:85143993164

SN - 0001-5555

VL - 102

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

M1 - adv00835

ER -

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

UN SDGs

Zugriff auf Dokument

Andere Dateien und Links

Projekte

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen

Zitieren